U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07154823) titled 'A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies' on Aug. 19.
Brief Summary: The TEMPUS AQUARIUS Study is a non-interventional, longitudinal observational study focused on hematological malignancies. It will collect rich molecular (multi-omic) and clinical data from patient cohorts through serial blood draws and the acquisition of leftover tissue and/or bone marrow aspirates during their routine therapy and disease monitoring. The primary goal is to understand the association between biomarkers and real-world clinical outcomes in these patient populations.
Study Start Dat...